Bio-Techne Corp - Common Stock (TECH)
60.12
-1.07 (-1.75%)
Bio-Techne Corp is a biotechnology company that specializes in developing and producing high-quality biotechnology tools and reagents for the life sciences market
The company offers a wide range of products, including proteins, antibodies, assays, and diagnostic tools, which are used by researchers and clinical laboratories for various applications, such as drug development, diagnostics, and disease research. With a focus on innovation, Bio-Techne aims to provide cutting-edge solutions that enhance research capabilities and improve patient outcomes in healthcare.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSEDHR) and the best and worst performers in the research tools & consumables industry.
Via StockStory · March 4, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Revvity (NYSERVTY) and the best and worst performers in the research tools & consumables industry.
Via StockStory · March 3, 2025

Healthcare services company Sotera Health (NASDAQ:)
will be reporting results tomorrow before market hours. Here’s what to look for.
Via StockStory · February 26, 2025

Via Benzinga · February 19, 2025

Life sciences tools company Agilent Technologies (NYSEA)
will be announcing earnings results tomorrow after market close. Here’s what you need to know.
Via StockStory · February 25, 2025

Via Benzinga · February 19, 2025

Scientific instrument company Bruker (NASDAQBRKR).
will be reporting results tomorrow before market hours. Here’s what investors should know.
Via StockStory · February 12, 2025

Biotech company 10x Genomics (NASDAQTXG)
will be reporting earnings tomorrow after market hours. Here’s what to look for.
Via StockStory · February 11, 2025

Scientific instruments company Waters Corporation (NYSEWAT)
will be reporting earnings tomorrow before the bell. Here’s what to look for.
Via StockStory · February 11, 2025

Curious about which S&P500 stocks are generating unusual volume on Monday? Find out below.
Via Chartmill · February 10, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · February 10, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Via Chartmill · February 10, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.
Via Chartmill · February 7, 2025

Let's have a look at the S&P500 stocks with an unusual volume in today's session.
Via Chartmill · February 6, 2025

Life sciences company Avantor (NYSEAVTR)
will be reporting earnings tomorrow before market hours. Here’s what you need to know.
Via StockStory · February 6, 2025

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · February 5, 2025

Genomics company Illumina (NASDAQILMN) will be reporting results tomorrow after the bell. Here’s what investors should know.
Via StockStory · February 5, 2025

Clinical research company IQVIA (NYSEIQV)
will be announcing earnings results tomorrow before market hours. Here’s what to look for.
Via StockStory · February 5, 2025

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via Chartmill · February 5, 2025

Precision measurement company Mettler-Toledo (NYSEMTD)
will be announcing earnings results tomorrow after market close. Here’s what to expect.
Via StockStory · February 5, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · February 5, 2025

Life sciences company Bio-Techne (NASDAQTECH) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 9% year on year to $297 million. Its non-GAAP profit of $0.42 per share was 9.3% above analysts’ consensus estimates.
Via StockStory · February 5, 2025

Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data.
Via Benzinga · February 5, 2025